C-reactive protein and cardiovascular disease in peritoneal dialysis patients

Kidney International

Volumn 62, Issue 4, 2002, Pages 1417-1422

  Ducloux, Didier ^a   Bresson Vautrin, Catherine ^a   Kribs, Marc ^a   Abdelfatah, Aboubakr ^a   Chalopin, Jean Marc ^a  

^a HÔPITAL SAINT JACQUES   (France)

Author keywords

Atherosclerosis; Chronic inflammation; Dialysis; Homocysteine; Malnutrition; Myocardial infarction risk; Risk factors

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC INFLAMMATION; CONTROLLED STUDY; DEATH; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPOALBUMINEMIA; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR;

EID: 0036379621     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2002.00562.x     Document Type: Article

References (34)

1. FOLEY RN, PARFREY PS, SARNAK MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32 (Suppl 3):112-119, 1998
2. U.S. RENAL DATA SYSTEM: USRDS Annual Data Report. Bethesda, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 1997
3. WILSON PW, D'AGOSTINO RB, LEVY D, et al: Prediction of coronary heart disease using risk factors categories. Circulation 97:1837-1847, 1998
4. BOSTOM AG, SHEMIN D, LAPANE KL, et al: Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: A matched case-control study. Atherosclerosis 125:91-101, 1996
5. BOAZ M, SMETANA S, WEINSTEIN T, et al: Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomized placebo-controlled trial. Lancet 356:1213-1218, 2000
6. COZZOLINO M, DUSSO AS, SLATOPOLSKY E: Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 12:2511-2516, 2001
7. CLYNE B, OLSHAKER JS: The C-reactive protein. J Emerg Med 17:1019-1025, 1999
8. RIDKER PM, CUSHMAN M, STAMPFER MJ: Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336:973-979, 1997
9. ZIMMERMANN J, HERRLINGER S, PRUY A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
10. ARICI M, WALLS J: End-stage renal disease, atherosclerosis, and cardiovascular mortality: Is C-reactive protein the missing link? Kidney Int 59:407-414, 2001
11. HAUBITZ M, BRUNKHORST R: C-reactive protein and chronic chlamydia pneumoniae infection - Long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis. Nephrol Dial Transplant 16:809-815, 2001
12. HERZIG KA, PURDIE DM, CHANG W, et al: Is C-reactive protein a useful predictor of outcome in peritoneal dialysis patients? J Am Soc Nephrol 12:814-821, 2001
13. FRIEDEWALD WT, LEVY RI, FREDRICKSON DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
14. DUCLOUX D, MOTTE G, CHALLIER B, et al: Serum total homocysteine and cardiovascular disease in chronic, stable renal transplant recipients: A prospective study. J Am Soc Nephrol 11:134-137, 2000
15. ZOCCALI C, BENEDETTO FA, MALLAMACI F, et al: Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis patients. J Hypertens 18:1207-1209, 2000
16. WANG AY, WOO J, WANG M, et al: Association of inflammation and malnutrition with cardiac valve calcification in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 12:1927-1936, 2001
17. EPSTEIN SE, ZHOU YF, ZHU J: Infection and atherosclerosis: Emerging mechanistic paradigms. Circulation 100:20-28, 1999
18. LAGRAND WK, NIESSEN HW, WOLBINK GJ, et al: C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction. Circulation 95:97-103, 1997
19. CERMAK J, KEY NS, BACH RR, et al: C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood 82:513-520, 1993
20. HAUBITZ M, BRUNKHORST R, WRENGER E, et al: Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Perit Dial Int 16:158-162, 1996
21. DOCCI D, BILANCIONI R, BUSCAROLI A, et al: Elevated serum levels of C-reactive protein in hemodialysis patients. Nephron 56:364-367, 1990
22. CHOLLET MS, STAMATAKIS G, BAILLY S, et al: Induction of tumor necrosis factor-alpha during haemodialysis. Influence of the membrane type. Clin Exp Immunol 83:329-332, 1991
23. BINGEL M, LONNEMAN G, SHALDON S, et al: Human interleukin-1 production during hemodialysis. Nephron 43:161-163, 1986
24. ISEKI K, TOZAWA M, YOSHI S, FUKIYAMA K: Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients. Nephrol Dial Transplant 14:1956-1960, 1999
25. YEUN JY, LEVINE RA, MANTADILOK V, KAYSEN GA: C-reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 35:469-476, 2000
26. OWEN WF, LOWRIE EG: C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54:627-636, 1998
27. NO H, LEE SW, KANG SW, et al: Serum C-reactive protein: a predictor of mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 18:387-394, 1998
28. KAYSEN GA, CHERTOW GM, ADHIKARIA R, et al: Inflammation and dietary protein intake exert competing effects on serum albumin and creatinine in hemodialysis patients. Kidney Int 60:333-340, 2001
29. LEVEL C, CHAUVEAU P, DELMAS Y, et al: Procalcitonin: A new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 16:980-986, 2001
30. QURESHI AR, ALVESTRAND A, DANIELSSON A, et al: Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 53:773-782, 1998
31. BOSTOM AG, SHEMIN D, VERHOEF P, et al: Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study. Arterioscler Thromb Vasc Biol 17:2554-2558, 1997
32. SULIMAN ME, QURESHI AR, BARANY P, et al: Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 57:1727-1735, 2000
33. DUCLOUX D, HEUZE-LECORNU L, GIBEY R, et al: Dialysis adequacy and homocysteine concentrations in peritoneal dialysis patients. Nephrol Dial Transplant 14:728-731, 1999
34. O'RIORDAN E, O'DONOGHUE DJ, KALRA PA, et al: Changes in lipid profiles in non diabetic, non nephrotic patients commencing continuous ambulatory peritoneal dialysis. Adv Perit Dial 16:313-316, 2000